Pathogenetic mechanisms in Parkinson's disease: studies with Positron Emission Tomography
Promotie: mw. A.L. Bartels, 16.15 uur, Academiegebouw, Broerstraat 5, Groningen
Proefschrift: Pathogenetic mechanisms in Parkinson's disease: studies with Positron Emission Tomography
Promotor(s): prof.dr. K.L. Leenders, prof.dr. R.A. Dierckx
Faculteit: Medische Wetenschappen
Contact: via de persvoorlichters van het UMCG, tel. 050-361 2200, e-mail: voorlichting bvl.umcg.nl
Pathogenetic mechanisms in Parkinson's disease: studies with Positron Emission Tomography
Parkinson’s disease (PD) is a progressive neurodegenerative disorder with a prevalence of approximately 1 % in the population above 65 years. For the development of treatments to prevent or slow this progressive disease, more knowledge of the pathogenesis is necessary. In this thesis, Positron Emission Tomography (PET) imaging is used to study the role of blood-brain barrier (BBB) dysfunction and neuroinflammation as possible contributory factors in PD pathogenesis. We found that decreased BBB P-gp function does not play a primary role in PD development, but may be involved in the progression of neurodegenerative disease. In a toxic PD animal model, treatment with a COX-2 inhibitor did not show diminished microglia activation, but did show decreased up-regulation of P-gp expressing vasculature after the toxic lesion.
Last modified: | 13 March 2020 01.16 a.m. |
More news
-
24 March 2025
UG 28th in World's Most International Universities 2025 rankings
The University of Groningen has been ranked 28th in the World's Most International Universities 2025 by Times Higher Education. With this, the UG leaves behind institutions such as MIT and Harvard. The 28th place marks an increase of five places: in...
-
05 March 2025
Women in Science
The UG celebrates International Women’s Day with a special photo series: Women in Science.
-
16 December 2024
Jouke de Vries: ‘The University will have to be flexible’
2024 was a festive year for the University of Groningen. In this podcast, Jouke de Vries, the chair of the Executive Board, looks back.